Pharmaron

Activities: Research & Development

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Pharmaron acquires Quotient Bioresearch

Deal will enhance service offerings and increase presence in global markets
Research & Development

Quotient Bioresearch to sell bioanalytical sciences division to LGC

Acquisition will enable LGC to offer bioanalysis, materials science and reference materials
Research & Development

Quotient Bioresearch opens new £1.5m bioanalytical facility

In response to increased demand for immunoassay and cell-based services from the Fordham, Cambridgeshire-based firm
Research & Development

Quotient Bioresearch expands molecular biology services

Adds Real-Time PCR to support screening of subjects
Manufacturing

Quotient and Capsugel form lipid formulations partnership

Aim to address issues of poor solubility
Research & Development

Management buyout at Quotient Bioresearch

Existing private equity shareholder provides finance
Research & Development

Merck Serono opens r&d laboratory in Beijing

Based on Pharmaron’s new campus
Subscribe now